EconStor >
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften / Leibniz-Informationszentrum Wirtschaft >
Intereconomics - Review of European Economic Policy >

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10419/42042
  

Full metadata record

DC FieldValueLanguage
dc.contributor.authorBoscheck, Ralfen_US
dc.date.accessioned2010-12-01T09:41:31Z-
dc.date.available2010-12-01T09:41:31Z-
dc.date.issued2008en_US
dc.identifier.citationIntereconomics 0020-5346 43 2008 5 277-281en_US
dc.identifier.pidoi:10.1007/s10272-008-0261-z-
dc.identifier.urihttp://hdl.handle.net/10419/42042-
dc.language.isoengen_US
dc.subject.ddc330en_US
dc.subject.stwArzneimittelrechten_US
dc.subject.stwVerbraucherschutzen_US
dc.subject.stwPharmazeutisches Produkten_US
dc.subject.stwDeregulierungen_US
dc.subject.stwGesundheitswesenen_US
dc.subject.stwUSAen_US
dc.subject.stwDeutschlanden_US
dc.titleOff-label drugs vs. the merits of centralised regulatory controlen_US
dc.typeArticleen_US
dc.identifier.ppn582112257en_US
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungenen_US
Appears in Collections:Intereconomics - Review of European Economic Policy

Files in This Item:
File Description SizeFormat
582112257.pdf50.61 kBAdobe PDF
No. of Downloads: Counter Stats
Show simple item record
Download bibliographical data as: BibTeX

Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.